Esperion Therapeutics, Inc. (ESPR) is currently trading at $3.17 with a Wall Street consensus price target of $3.19, implying potential upside of 0.6% over the next 12 months. 4 analysts currently cover ESPR, with a consensus rating of Buy — 75% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $3.28, while the most cautious has a target of $3.16.
ESPR operates in the Healthcare sector with a market capitalisation of $817M. The stock is down 14.6% year-to-date and is currently trading near the upper end of its 52-week range of $0.95 – $4.18.
Other Healthcare stocks with comparable size and valuation.
Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.
Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.
StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.
View Full Rankings →